Stay updated on Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page.

Latest updates to the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page
- Check6 days agoChange DetectedPoland site 1505 in Wrocław was updated: EMC Instytut Medyczny SA (54-144) was removed on 2025-12-26 and replaced with Penta Hospitals Przychodnie Wrocław Wejherowska (54-239) added on 2026-01-09.SummaryDifference0.1%

- Check13 days agoChange DetectedA new label Last Update Posted (Estimated) has been added to Study Record Dates, replacing the previous Last Update Posted label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedAdded Nitra, Nitra Region, Slovakia with postal code 949 01 (2025-12-26) and removed the previous 94901 entry (2025-12-18).SummaryDifference0.0%

- Check28 days agoChange DetectedAdded a comprehensive list of new trial locations across the United States, Argentina, Australia, and multiple regions in Europe, Asia, and more. This expansion increases geographic coverage and provides more sites for potential participants.SummaryDifference4%

- Check35 days agoChange DetectedTwo new sites were added to the study: Prairie Institute of Liver and Luminal Advanced Research in Bucharest, Romania (Site 0013) and Monza Ares SRL in Monza, Italy (Site 1604). The previous sites SIX08 Gastroenterology in Bucharest (Site 0013) and S.C. Centrul Medical Medicum SRL-Gastroenterology (Site 1604) were removed.SummaryDifference0.1%

- Check42 days agoChange DetectedThe study's site list expanded to 476 locations, including Seattle (University of Washington Medical Center – Montlake), Santo André, Poznan, Pratia Poznan, and Nitra. The total locations increased from 472 to 476, dates were updated to 2025-12-02, 2026-08-01, and 2029-08-01, and extensive contact details were removed.SummaryDifference12%

Stay in the know with updates to Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page.